← Back to headlines
Immunology Drug Developer Odyssey Prices Upsized IPO
Odyssey, a company focused on developing immunology drugs, has successfully priced its upsized initial public offering, indicating strong investor interest in its market debut.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
